Related Experiment Videos
Case study: end stage liver failure patient managed with CAVH pretransplant
Summary
Continuous venovenous hemofiltration (CVVH) therapy proved effective for critically ill patients. Nursing recommendations emphasize hourly bedside activated clotting time (ACT) tests for patients with coagulopathy during CVVH.
Area of Science:
- Nephrology
- Critical Care Medicine
Background:
- Continuous venovenous hemofiltration (CVVH) is a vital treatment for critically ill patients with multi-organ involvement.
- Effective management requires seamless integration of nursing care across intensive care and operating room settings.
Observation:
- Catheter function was maintained without infection, bleeding, or thrombosis during CVVH.
- The patient required vasopressors briefly but met most therapeutic goals.
- Anticoagulation management presented a challenge, with one instance of elevated activated partial thromboplastin time (aPTT).
Findings:
- CVVH therapy was successfully implemented and maintained in both ICU and OR environments.
- The patient's fluid balance, nutritional needs, and vital signs were adequately supported.
- A specific nursing recommendation emerged for hourly bedside ACTs alongside every 4-hour aPTTs in patients with coagulopathy.
Implications:
- CRRT therapies facilitate interdisciplinary collaboration between nephrology and critical care nursing.
- Focus is shifting from technical CRRT aspects to patient-centered nursing care.
- Enhanced monitoring protocols, like routine bedside ACTs, can improve anticoagulation safety in complex patients.